Ajanta Pharma Limited — Quarter ended 31 March 2026 (FY ended 31 March 2026)
| Milestone | Value |
|---|---|
| Revenue crosses | 5,000 cr. |
| PAT crosses | 1,000 cr. |
| EBITDA close to | 1,500 cr. |
| IPM Rank | 24 |
| Markets | Q4 FY 2025 | Q4 FY 2026 | Gwth% | FY FY 2025 | FY FY 2026 | Gwth% |
|---|---|---|---|---|---|---|
| Branded Generics | ||||||
| India | ₹ 369 | ₹ 404 | 9% | ₹ 1,452 | ₹ 1,654 | 14% |
| Asia | ₹ 303 | ₹ 274 | (10%) | ₹ 1,191 | ₹ 1,175 | (1%) |
| Africa | ₹ 133 | ₹ 182 | 37% | ₹ 750 | ₹ 861 | 15% |
| Sub-Total | ₹ 805 | ₹ 859 | 7% | ₹ 3,394 | ₹ 3,690 | 9% |
| US Generic | ₹ 325 | ₹ 505 | 56% | ₹ 1,047 | ₹ 1,557 | 49% |
| Africa Institution | ₹ 28 | ₹ 48 | 71% | ₹ 147 | ₹ 160 | 9% |
| Total | ₹ 1,158 | ₹ 1,412 | 22% | ₹ 4,588 | ₹ 5,407 | 18% |
| Date and Time | May 05, 2026 at 16:30 – 17:30 hrs IST 19:00 – 20:00 hrs SST/HKT 12:00 – 13:00 hrs BST 07:00 – 08:00 hrs US ET |
|---|---|
| Dial-in Numbers | Diamond pass link for faster access: Click here to register Universal Access: Primary Access: (+91 22 6280 1542) (+91 22 7115 8372) International Toll Free: USA: 18667462133 UK: 08081011573 Hong Kong: 800964448 Singapore: 8001012045 |
| Particulars | Quarter ended 31-Mar-26 (Audited) |
Quarter ended 31-Dec-25 (Unaudited) |
Quarter ended 31-Mar-25 (Audited) |
Year ended 31-Mar-26 (Audited) |
Year ended 31-Mar-25 (Audited) |
|---|---|---|---|---|---|
| Income | |||||
| Revenue from operations | 1,421.64 | 1,374.84 | 1,170.41 | 5,452.86 | 4,648.10 |
| Other income (Refer note 4) | 61.43 | 24.97 | 18.11 | 172.07 | 94.50 |
| Total Income | 1,483.07 | 1,399.81 | 1,188.52 | 5,624.93 | 4,742.60 |
| Expenses | |||||
| Cost of materials consumed | 256.76 | 235.07 | 190.96 | 916.51 | 846.60 |
| Purchases of stock-in-trade | 71.35 | 53.55 | 80.18 | 229.79 | 249.80 |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | (23.30) | (2.36) | 12.28 | 37.46 | (25.64) |
| Employee benefits expense | 340.72 | 330.52 | 279.78 | 1,291.15 | 1,089.69 |
| Finance costs | 2.36 | 5.10 | 6.07 | 16.11 | 20.73 |
| Depreciation and amortisation expense | 45.37 | 43.51 | 39.78 | 173.14 | 144.11 |
| Other expenses (Refer note 4) | 442.70 | 375.82 | 310.06 | 1,583.12 | 1,228.15 |
| Total Expenses | 1,135.96 | 1,041.21 | 919.11 | 4,247.28 | 3,553.44 |
| Profit before and after exceptional items but before tax | 347.11 | 358.60 | 269.41 | 1,377.65 | 1,189.16 |
| Tax Expense | |||||
| Current Tax | 61.40 | 86.88 | 61.96 | 300.08 | 312.30 |
| Deferred Tax | 19.01 | (2.05) | (17.81) | 21.57 | (43.53) |
| Profit for the period | 266.70 | 273.77 | 225.26 | 1,056.00 | 920.39 |
| Other Comprehensive Income (OCI) | |||||
| Items that will be reclassified subsequently to profit or loss | 15.83 | 2.32 | 3.47 | 29.39 | 7.68 |
| Income tax relating to items that will be reclassified subsequently to profit or loss | – | – | – | – | – |
| Items that will not be reclassified subsequently to profit or loss | 3.51 | 0.28 | (2.19) | (0.48) | (8.96) |
| Income tax relating to items that will not be reclassified to profit or loss | (1.23) | (0.09) | 0.76 | 0.17 | 3.13 |
| Other Comprehensive Income / (loss) for the year, net of tax | 18.11 | 2.51 | 2.04 | 29.08 | 1.85 |
| Total Comprehensive Income for the period | 284.81 | 276.28 | 227.30 | 1,085.08 | 922.24 |
| Paid-up Equity Share Capital (Face value of ₹ 2 each) | 25.07 | 25.07 | 25.07 | 25.07 | 25.07 |
| Other Equity | 4,502.02 | 3,765.22 | |||
| Earnings Per Share (Face value of ₹ 2 each) | |||||
| (a) Basic – in ₹ | 21.35 | 21.91 | 18.00 | 84.53 | 73.56 |
| (b) Diluted – in ₹ | 21.34 | 21.91 | 18.00 | 84.51 | 73.53 |
| ₹ in Crore | Quarter ended 31-Mar-26 | Quarter ended 31-Dec-25 | Quarter ended 31-Mar-25 | Year ended 31-Mar-26 | Year ended 31-Mar-25 |
|---|---|---|---|---|---|
| Foreign exchange gain (in other income) | 44.37 | 8.55 | 7.06 | 97.17 | 28.21 |
| Foreign exchange loss (in other expense) | 41.70 | – | – | 103.04 | 8.82 |
| Particulars | 31-Mar-26 Audited | 31-Mar-25 Audited |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Property, plant and equipment | 1,726.35 | 1,624.87 |
| Capital work-in-progress | 258.05 | 176.27 |
| Right to use assets | 99.02 | 90.63 |
| Other Intangible assets | 41.58 | 46.52 |
| Financial assets | ||
| – Investments | 28.50 | 25.24 |
| – Other financial assets | 7.99 | 9.25 |
| Deferred tax assets (net) | 188.59 | 186.43 |
| Income tax assets (net) | 7.56 | – |
| Other non-current assets | 61.77 | 12.71 |
| Total non-current assets | 2,419.41 | 2,171.92 |
| Current assets | ||
| Inventories | 938.54 | 903.85 |
| Financial assets | ||
| – Investments | 559.85 | 438.71 |
| – Trade receivables | 1,853.88 | 1,182.74 |
| Cash and cash equivalents | 103.26 | 175.12 |
| Bank balances other than cash and cash equivalents | 1.51 | 1.12 |
| Loans | 1.68 | 2.54 |
| Other financial assets | 8.98 | 2.32 |
| Other current assets | 267.73 | 123.30 |
| 3,735.43 | 2,829.70 | |
| Assets classified as held for sale | – | 13.33 |
| Total current assets | 3,735.43 | 2,843.03 |
| Total assets | 6,154.84 | 5,014.95 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 25.07 | 25.07 |
| Other equity | 4,502.02 | 3,765.22 |
| Total equity | 4,527.09 | 3,790.29 |
| Non-current liabilities | ||
| Financial liabilities | ||
| – Lease liabilities | 39.42 | 34.72 |
| – Other financial liabilities | 1.82 | 1.05 |
| Other non-current liabilities | 1.67 | 2.00 |
| Provisions | 51.15 | 80.27 |
| Deferred tax liabilities (net) | 117.94 | 110.52 |
| Total non-current liabilities | 212.00 | 228.56 |
| Current liabilities | ||
| Financial liabilities | ||
| – Borrowings | 211.99 | 2.59 |
| – Trade payables | ||
| (a) total outstanding dues of micro and small enterprises | 54.17 | 21.55 |
| (b) total outstanding dues of creditors other than micro and small enterprises | 490.13 | 432.65 |
| – Other financial liabilities | 495.82 | 374.20 |
| – Lease liabilities | 8.76 | 10.11 |
| Other current liabilities | 119.00 | 91.12 |
| Provisions | 30.39 | 23.35 |
| Income tax liabilities (net) | 5.49 | 40.53 |
| Total current liabilities | 1,415.75 | 996.10 |
| Total liabilities | 1,627.75 | 1,224.66 |
| Total Equity and Liabilities | 6,154.84 | 5,014.95 |
| Particulars | 31-Mar-26 Audited | 31-Mar-25 Audited |
|---|---|---|
| A. Cash flow from operating activities | ||
| Profit before tax | 1,377.65 | 1,189.16 |
| Adjustment for : | ||
| – Depreciation and amortisation expense | 173.14 | 144.11 |
| – Loss / (gain) on sale / retirement of property, plant and equipment (net) | 1.87 | 0.60 |
| – Finance costs | 16.11 | 20.73 |
| – Loss / (Gain) on investment at FVTPL | (1.55) | 3.65 |
| – Loss / (Gain) on fair value of derivative | 88.92 | 8.82 |
| – Loss / (Gain) on sale/redemption of Current Investments | (8.70) | (14.99) |
| – Interest income on investments and deposits | (51.60) | (44.08) |
| – Deferred government grant | (0.33) | (0.33) |
| – Equity settled share based payment | 1.53 | 3.88 |
| – Unrealised foreign exchange loss / (gain) | (58.14) | (10.31) |
| – Impairment (Gain) / loss on financial assets | 2.21 | 0.03 |
| Operating cash flow before working capital changes | 1,541.11 | 1,301.27 |
| Changes in working capital | ||
| – Decrease / (Increase) in trade receivables | (590.84) | 80.48 |
| – Decrease / (Increase) in other receivable | (158.82) | 25.29 |
| – Decrease / (Increase) in inventories | (30.95) | (74.51) |
| – (Decrease) / Increase in trade payable | 90.79 | (8.45) |
| – Increase / (Decrease) in other payable | 59.28 | 115.64 |
| – Increase / (Decrease) in provisions | (22.39) | 40.48 |
| Cash generated from operating activities | 888.18 | 1,480.20 |
| – Net income tax paid | (358.99) | (322.97) |
| Net cash generated from operating activities | 529.19 | 1,157.23 |
| B. Cash flow from investing activities | ||
| Capital expenditure on property, plant and equipment & intangible assets including capital advances | (365.16) | (317.92) |
| Proceeds from sale of property, plant and equipment | 5.41 | 1.14 |
| Bank balances not considered as cash and cash equivalents | (0.39) | 0.16 |
| Purchase of current investments | (2,659.98) | (2,761.21) |
| Proceeds from sale of current investments | 2,549.09 | 2,663.48 |
| Income on investments and deposits | 45.37 | 44.08 |
| Investment in Limited Liability Partnership – Non Current Investment | (3.26) | (6.25) |
| Net cash used in investing activities | (428.92) | (376.52) |
| C. Cash flow from financing activities | ||
| Proceeds from Issue of Equity Shares (31 March 2026 ₹ 47,050, 31 March 2025 ₹ 50,650) | – | 0.01 |
| Proceeds / (repayment) of borrowings (net) | 209.40 | 1.10 |
| Interest paid | (12.80) | (17.31) |
| Payment of lease liability (includes interest of Rs. 3.31 crores in current year and Rs. 3.43 crores in previous year) | (14.80) | (14.89) |
| (Payment) for buyback of equity shares | – | (351.34) |
| Income / (payment) for expenses for buyback of equity shares | – | (1.61) |
| Dividend paid | (349.72) | (349.37) |
| Net cash used in financing activities | (167.92) | (733.41) |
| Net increase / (decrease) in cash and cash equivalents | (67.65) | 47.30 |
| Cash and cash equivalents as at the beginning of the year | 175.12 | 129.49 |
| Cash and cash equivalents as at the end of the year | 107.47 | 176.79 |
| Particulars | 31-Mar-26 | 31-Mar-25 |
|---|---|---|
| Cash and cash equivalents as at the end of the year | 107.47 | 176.79 |
| Unrealised loss / (gain) on foreign currency cash and cash equivalents | (4.21) | (1.67) |
| Cash and cash equivalents restated balance as per balance sheet | 103.26 | 175.12 |
| Particulars | Quarter ended (Audited) 31-Mar-26 | Quarter ended (Unaudited) 31-Dec-25 | Quarter ended (Audited) 31-Mar-25 | Year ended (Audited) 31-Mar-26 | Year ended (Audited) 31-Mar-25 |
|---|---|---|---|---|---|
| Income | |||||
| Revenue from operations | 1,210.53 | 1,206.59 | 1,013.94 | 4,845.92 | 4,322.04 |
| Other income (Refer note 3) | 62.98 | 25.76 | 17.93 | 204.40 | 119.87 |
| Total Income | 1,273.51 | 1,232.35 | 1,031.87 | 5,050.32 | 4,441.91 |
| Expenses | |||||
| Cost of materials consumed | 256.77 | 235.07 | 190.96 | 916.52 | 846.60 |
| Purchases of stock-in-trade | 57 |